Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2109]

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Bridge therapy may benefit some children with high-risk neuroblastoma

Bridge therapy may benefit some children with high-risk neuroblastoma

ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer patients with brain metastases

Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer...

ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma

ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma

A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer

A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer

Epilepsy drug stops nervous system tumour growth in mice

Epilepsy drug stops nervous system tumour growth in mice

More from ecancer